European Medicines Agency Completes Arbitration Over Bayer Product

Date : 04/20/2012 @ 1:46PM
Source : Dow Jones News
Stock : Bayer AG NA O.N. (BAYN)
Quote : 92.75  -1.46 (-1.55%) @ 12:30PM
Bayer share price Chart

European Medicines Agency Completes Arbitration Over Bayer Product

Bayer (XE:BAY001)
Historical Stock Chart

5 Years : From Mar 2013 to Mar 2018

Click Here for more Bayer Charts.

The European Medicines Agency said Friday that on April 19 it completed an arbitration procedure following a disagreement among European Union member states regarding the authorization of the medicine Yvidually, a combined contraceptive pill, and associated names.

The Agency's Committee for Medicinal Products for Human Use, or CHMP, concluded that the benefits of Yvidually outweigh its risks, and the marketing authorization can be granted in all EU member states as well as Iceland and Norway, the agency said in a statement.

Bayer B.V., the Dutch unit of Bayer AG (BAYN.XE, BAYRY) submitted Yvidually to the Netherlands medicines regulatory agency for a decentralized procedure. This is a procedure where one member state assesses a medicine with a view to granting a marketing authorization that will be valid in this country as well as in other member states.

The grounds for the referral were concerns by France about the effectiveness of the proposed extended use of the medicine and the irregular bleeding episodes that might occur during the days of intake of the pill, the agency said. France was also concerned that the tablet dispenser hadn't been used in the main clinical studies.

-By Frankfurt Newsroom, Dow Jones Newswires; +49 69 29725 500

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:31 V:us D:20180323 05:02:30